Tetraspan 60 mg/ml infusionsvæske, opløsning דנמרק - דנית - Lægemiddelstyrelsen (Danish Medicines Agency)

tetraspan 60 mg/ml infusionsvæske, opløsning

b. braun melsungen - Æblesyre, calciumchloriddihydrat, hydroxyethylstivelse, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning - 60 mg/ml

Venofundin 60 mg/ml infusionsvæske דנמרק - דנית - Lægemiddelstyrelsen (Danish Medicines Agency)

venofundin 60 mg/ml infusionsvæske

b. braun melsungen - hydroxyethylstivelse, natriumchlorid - infusionsvæske - 60 mg/ml

Nipruss 60 mg pulver til infusionsvæske, opløsning דנמרק - דנית - Lægemiddelstyrelsen (Danish Medicines Agency)

nipruss 60 mg pulver til infusionsvæske, opløsning

Øresund pharma aps - natriumnitroprussiddihydrat - pulver til infusionsvæske, opløsning - 60 mg

Sapropterin Dipharma האיחוד האירופי - דנית - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.